Compare KYN & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | KYN | HTFL |
|---|---|---|
| Founded | 2004 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.2B |
| IPO Year | 2004 | 2025 |
| Metric | KYN | HTFL |
|---|---|---|
| Price | $14.25 | $49.63 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $46.00 |
| AVG Volume (30 Days) | 316.4K | ★ 1.5M |
| Earning Date | 01-01-0001 | 11-11-2026 |
| Dividend Yield | ★ 8.99% | N/A |
| EPS Growth | N/A | ★ 82.37 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,034,000.00 |
| Revenue This Year | N/A | $41.33 |
| Revenue Next Year | N/A | $24.23 |
| P/E Ratio | $20.75 | ★ N/A |
| Revenue Growth | N/A | ★ 39.92 |
| 52 Week Low | $11.31 | $20.13 |
| 52 Week High | $15.17 | $54.32 |
| Indicator | KYN | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 50.99 | 54.26 |
| Support Level | $13.59 | $46.44 |
| Resistance Level | $14.35 | $51.73 |
| Average True Range (ATR) | 0.24 | 2.49 |
| MACD | 0.04 | -0.49 |
| Stochastic Oscillator | 79.38 | 39.39 |
Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.